Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Lars Peterson joined Investopedia in 2023 as a senior editor of financial product ...

Librephone is a new initiative by the FSF with the goal of bringing full freedom to the mobile computing environment. The vast majority of software users around the world use a mobile phone as their ...

The rings of DNA inside mitochondria are inaccessible to these techniques, which means that precise edits to mitochondrial DNA (mtDNA) remain frustratingly out of reach. “Mitochondria missed the ...

Owners of some Jeep Wrangler 4xe hybrids have been left stranded after installing an over-the-air software update this weekend. The automaker pushed out a telematics update for the Uconnect ...

Editor’s note: Jeep’s parent automaker, Stellantis, issued a recall for the affected Wrangler 4xes Oct. 22, 2025. Jeep pushed out an over-the-air software update on Friday, Oct. 10, that apparently ...

Forbes contributors publish independent expert analyses and insights. Nick Nuttall is a journalist and presenter for We Don’t Have Time.

Fintel reports that on October 10, 2025, Needham reiterated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 11.29% Upside As of September 30, ...